Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet | 5 | 2023 | 826 | 1.420 |
Why?
|
| Health Status Disparities | 2 | 2021 | 719 | 0.830 |
Why?
|
| Food | 1 | 2023 | 103 | 0.760 |
Why?
|
| Nutrition Assessment | 1 | 2023 | 80 | 0.750 |
Why?
|
| Fatty Liver | 2 | 2021 | 77 | 0.740 |
Why?
|
| Databases, Factual | 5 | 2020 | 341 | 0.730 |
Why?
|
| Accidents, Traffic | 2 | 2020 | 48 | 0.720 |
Why?
|
| United States | 17 | 2025 | 5205 | 0.670 |
Why?
|
| Neck Injuries | 1 | 2019 | 10 | 0.620 |
Why?
|
| Head Protective Devices | 1 | 2019 | 11 | 0.620 |
Why?
|
| Injury Severity Score | 1 | 2019 | 69 | 0.620 |
Why?
|
| Craniocerebral Trauma | 1 | 2019 | 22 | 0.610 |
Why?
|
| Bicycling | 1 | 2019 | 18 | 0.610 |
Why?
|
| Mexican Americans | 1 | 2021 | 226 | 0.590 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 193 | 0.560 |
Why?
|
| Hospital Mortality | 2 | 2019 | 210 | 0.550 |
Why?
|
| Humans | 46 | 2025 | 43102 | 0.530 |
Why?
|
| Pancreatitis | 2 | 2007 | 21 | 0.490 |
Why?
|
| Dementia, Vascular | 1 | 2016 | 35 | 0.480 |
Why?
|
| Male | 34 | 2025 | 23409 | 0.450 |
Why?
|
| Adult | 26 | 2023 | 13872 | 0.450 |
Why?
|
| Inpatients | 1 | 2016 | 78 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 760 | 0.450 |
Why?
|
| Puberty | 2 | 2025 | 31 | 0.450 |
Why?
|
| Female | 34 | 2025 | 24698 | 0.440 |
Why?
|
| Middle Aged | 24 | 2023 | 12222 | 0.420 |
Why?
|
| Stress, Psychological | 3 | 2025 | 661 | 0.420 |
Why?
|
| Nutrition Surveys | 5 | 2021 | 263 | 0.410 |
Why?
|
| Dementia | 1 | 2015 | 160 | 0.410 |
Why?
|
| Aged | 19 | 2023 | 8214 | 0.400 |
Why?
|
| Diabetes Mellitus | 3 | 2016 | 539 | 0.400 |
Why?
|
| Adolescent | 15 | 2025 | 6081 | 0.400 |
Why?
|
| Aged, 80 and over | 11 | 2016 | 2853 | 0.380 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 51 | 0.370 |
Why?
|
| Young Adult | 9 | 2021 | 5080 | 0.360 |
Why?
|
| Treatment Outcome | 4 | 2020 | 1604 | 0.350 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2003 | 146 | 0.350 |
Why?
|
| Risk Factors | 9 | 2025 | 3994 | 0.310 |
Why?
|
| Prevalence | 5 | 2021 | 1612 | 0.310 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 1001 | 0.280 |
Why?
|
| Multiple Organ Failure | 1 | 2007 | 8 | 0.270 |
Why?
|
| Jaundice | 1 | 2007 | 7 | 0.270 |
Why?
|
| Hospitalization | 4 | 2015 | 485 | 0.260 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2007 | 8 | 0.260 |
Why?
|
| Proton Pump Inhibitors | 1 | 2007 | 16 | 0.260 |
Why?
|
| Albuminuria | 2 | 2020 | 78 | 0.260 |
Why?
|
| Cross Infection | 1 | 2007 | 48 | 0.250 |
Why?
|
| Diarrhea | 1 | 2007 | 95 | 0.250 |
Why?
|
| Substance-Related Disorders | 2 | 2025 | 830 | 0.250 |
Why?
|
| Comorbidity | 3 | 2016 | 737 | 0.240 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2007 | 226 | 0.230 |
Why?
|
| Hepatitis C | 1 | 2006 | 139 | 0.220 |
Why?
|
| Dyspepsia | 1 | 2004 | 6 | 0.210 |
Why?
|
| Neurosecretory Systems | 1 | 2024 | 17 | 0.210 |
Why?
|
| Retrospective Studies | 6 | 2023 | 2544 | 0.210 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2023 | 9 | 0.210 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2023 | 10 | 0.200 |
Why?
|
| Child | 7 | 2025 | 3443 | 0.200 |
Why?
|
| Xylans | 2 | 2016 | 28 | 0.200 |
Why?
|
| Healthcare Disparities | 2 | 2023 | 590 | 0.200 |
Why?
|
| Geriatric Assessment | 1 | 2023 | 66 | 0.190 |
Why?
|
| Regression Analysis | 2 | 2021 | 490 | 0.190 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 71 | 0.190 |
Why?
|
| Cultural Diversity | 2 | 2019 | 193 | 0.180 |
Why?
|
| Sex Characteristics | 1 | 2024 | 258 | 0.180 |
Why?
|
| Eating | 1 | 2023 | 167 | 0.180 |
Why?
|
| Veterans | 1 | 2023 | 210 | 0.170 |
Why?
|
| Chronic Disease | 2 | 2023 | 549 | 0.170 |
Why?
|
| Population Surveillance | 3 | 2017 | 246 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2023 | 989 | 0.160 |
Why?
|
| Alcohol Drinking | 1 | 2025 | 609 | 0.160 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 3156 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 167 | 0.150 |
Why?
|
| Age Distribution | 1 | 2020 | 249 | 0.150 |
Why?
|
| Curcumin | 1 | 2020 | 118 | 0.150 |
Why?
|
| Education | 1 | 2019 | 60 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 140 | 0.150 |
Why?
|
| Trauma Centers | 1 | 2019 | 92 | 0.150 |
Why?
|
| Physicians | 1 | 2021 | 188 | 0.150 |
Why?
|
| Erectile Dysfunction | 1 | 2019 | 39 | 0.140 |
Why?
|
| Sex Distribution | 2 | 2017 | 224 | 0.140 |
Why?
|
| Los Angeles | 4 | 2010 | 394 | 0.140 |
Why?
|
| Research Personnel | 1 | 2019 | 206 | 0.140 |
Why?
|
| Exercise | 1 | 2023 | 692 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 278 | 0.130 |
Why?
|
| Viremia | 1 | 2016 | 44 | 0.120 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 44 | 0.120 |
Why?
|
| Acute Disease | 2 | 2007 | 155 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 203 | 0.120 |
Why?
|
| Biomedical Research | 2 | 2019 | 502 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2017 | 201 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2016 | 195 | 0.110 |
Why?
|
| Adolescent Development | 2 | 2025 | 40 | 0.110 |
Why?
|
| Cartoons as Topic | 1 | 2014 | 3 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2014 | 15 | 0.110 |
Why?
|
| Depression | 2 | 2016 | 863 | 0.100 |
Why?
|
| Shock, Septic | 1 | 2014 | 20 | 0.100 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 26 | 0.100 |
Why?
|
| Minority Groups | 1 | 2019 | 690 | 0.100 |
Why?
|
| Cognition | 1 | 2017 | 473 | 0.100 |
Why?
|
| Empathy | 1 | 2013 | 33 | 0.100 |
Why?
|
| Diabetes Complications | 1 | 2014 | 102 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2003 | 31 | 0.100 |
Why?
|
| California | 5 | 2014 | 548 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1019 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 235 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2023 | 1285 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2013 | 129 | 0.090 |
Why?
|
| Stroke | 1 | 2016 | 340 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 242 | 0.090 |
Why?
|
| Pyrazines | 1 | 2011 | 32 | 0.090 |
Why?
|
| Health Literacy | 1 | 2014 | 130 | 0.090 |
Why?
|
| Sex Factors | 2 | 2025 | 1028 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 49 | 0.090 |
Why?
|
| Triazoles | 1 | 2011 | 102 | 0.080 |
Why?
|
| Sunburn | 1 | 2010 | 5 | 0.080 |
Why?
|
| Sunlight | 1 | 2010 | 48 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 184 | 0.080 |
Why?
|
| Nicotine | 1 | 2012 | 302 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2007 | 128 | 0.070 |
Why?
|
| Hypertension | 1 | 2016 | 835 | 0.070 |
Why?
|
| Parenting | 1 | 2010 | 137 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 163 | 0.070 |
Why?
|
| Health Services Accessibility | 2 | 2011 | 706 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2007 | 19 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 224 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 44 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2014 | 587 | 0.070 |
Why?
|
| Age Factors | 2 | 2025 | 1154 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2007 | 25 | 0.060 |
Why?
|
| Health Education | 1 | 2010 | 363 | 0.060 |
Why?
|
| Hypoglycemia | 1 | 2007 | 24 | 0.060 |
Why?
|
| Colonic Diseases | 1 | 2006 | 11 | 0.060 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2006 | 14 | 0.060 |
Why?
|
| Research Design | 2 | 2023 | 385 | 0.060 |
Why?
|
| Adolescent Health Services | 1 | 2006 | 29 | 0.060 |
Why?
|
| Child Health Services | 1 | 2006 | 42 | 0.060 |
Why?
|
| Liver | 2 | 2023 | 511 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2006 | 61 | 0.060 |
Why?
|
| Colon | 1 | 2006 | 120 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2023 | 1600 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2021 | 359 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2006 | 154 | 0.060 |
Why?
|
| Pregnancy, Ectopic | 1 | 2005 | 15 | 0.060 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2004 | 2 | 0.060 |
Why?
|
| Public Housing | 1 | 2005 | 16 | 0.060 |
Why?
|
| Gallstones | 1 | 2004 | 8 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2006 | 117 | 0.060 |
Why?
|
| Focus Groups | 2 | 2019 | 423 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2006 | 178 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2013 | 1546 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2004 | 42 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2004 | 23 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2004 | 33 | 0.050 |
Why?
|
| Testosterone | 1 | 2025 | 211 | 0.050 |
Why?
|
| Radiography | 1 | 2004 | 71 | 0.050 |
Why?
|
| Pregnancy | 2 | 2006 | 1772 | 0.050 |
Why?
|
| ROC Curve | 1 | 2023 | 159 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 432 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 140 | 0.050 |
Why?
|
| Biopsy | 1 | 2023 | 177 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 67 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 81 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2025 | 281 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2023 | 108 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2006 | 925 | 0.050 |
Why?
|
| Food Supply | 1 | 2023 | 122 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1063 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 298 | 0.040 |
Why?
|
| Infant | 3 | 2013 | 1175 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 758 | 0.040 |
Why?
|
| Urban Population | 1 | 2003 | 374 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 105 | 0.040 |
Why?
|
| Sirolimus | 1 | 2020 | 70 | 0.040 |
Why?
|
| Mentors | 1 | 2021 | 145 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 99 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 440 | 0.040 |
Why?
|
| Base Sequence | 1 | 2020 | 983 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 1234 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 299 | 0.040 |
Why?
|
| Quality of Life | 1 | 2023 | 616 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 667 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 592 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 863 | 0.030 |
Why?
|
| Ribavirin | 1 | 2016 | 21 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2013 | 972 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 186 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 284 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 234 | 0.030 |
Why?
|
| Health Surveys | 1 | 2017 | 405 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 179 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 269 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 348 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 968 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2020 | 518 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1455 | 0.030 |
Why?
|
| Video Recording | 1 | 2014 | 41 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 147 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 2676 | 0.020 |
Why?
|
| HIV Infections | 1 | 2007 | 2586 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2013 | 74 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 27 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 42 | 0.020 |
Why?
|
| Animal Feed | 1 | 2012 | 53 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 68 | 0.020 |
Why?
|
| Triglycerides | 1 | 2012 | 147 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2012 | 80 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2012 | 108 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 40 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 2157 | 0.020 |
Why?
|
| Ethiodized Oil | 1 | 2010 | 3 | 0.020 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2010 | 6 | 0.020 |
Why?
|
| Psychometrics | 1 | 2013 | 358 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2014 | 574 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 32 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1078 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 48 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2010 | 34 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 240 | 0.020 |
Why?
|
| Telephone | 1 | 2010 | 36 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 352 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2010 | 97 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 317 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 374 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 154 | 0.020 |
Why?
|
| Social Class | 1 | 2011 | 291 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 318 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 178 | 0.020 |
Why?
|
| Ethanol | 1 | 2010 | 224 | 0.020 |
Why?
|
| Universities | 1 | 2011 | 559 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 760 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 1067 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1869 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 48 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 1003 | 0.020 |
Why?
|
| Eyeglasses | 1 | 2006 | 22 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2006 | 152 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2006 | 122 | 0.010 |
Why?
|
| Apoptosis | 1 | 2012 | 1568 | 0.010 |
Why?
|
| Data Collection | 1 | 2005 | 210 | 0.010 |
Why?
|
| Health Promotion | 1 | 2010 | 704 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 6644 | 0.010 |
Why?
|
| Health Status | 1 | 2005 | 442 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 16992 | 0.010 |
Why?
|